CDK5_HUMAN - dbPTM
CDK5_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID CDK5_HUMAN
UniProt AC Q00535
Protein Name Cyclin-dependent-like kinase 5
Gene Name CDK5
Organism Homo sapiens (Human).
Sequence Length 292
Subcellular Localization Isoform 1: Cytoplasm. Cell membrane
Peripheral membrane protein. Perikaryon. Cell projection, lamellipodium. Cell projection, growth cone. Cell junction, synapse, postsynaptic cell membrane, postsynaptic density. In axonal growth cone with extension
Protein Description Proline-directed serine/threonine-protein kinase essential for neuronal cell cycle arrest and differentiation and may be involved in apoptotic cell death in neuronal diseases by triggering abortive cell cycle re-entry. Interacts with D1 and D3-type G1 cyclins. Phosphorylates SRC, NOS3, VIM/vimentin, p35/CDK5R1, MEF2A, SIPA1L1, SH3GLB1, PXN, PAK1, MCAM/MUC18, SEPT5, SYN1, DNM1, AMPH, SYNJ1, CDK16, RAC1, RHOA, CDC42, TONEBP/NFAT5, MAPT/TAU, MAP1B, histone H1, p53/TP53, HDAC1, APEX1, PTK2/FAK1, huntingtin/HTT, ATM, MAP2, NEFH and NEFM. Regulates several neuronal development and physiological processes including neuronal survival, migration and differentiation, axonal and neurite growth, synaptogenesis, oligodendrocyte differentiation, synaptic plasticity and neurotransmission, by phosphorylating key proteins. Activated by interaction with CDK5R1 (p35) and CDK5R2 (p39), especially in post-mitotic neurons, and promotes CDK5R1 (p35) expression in an autostimulation loop. Phosphorylates many downstream substrates such as Rho and Ras family small GTPases (e.g. PAK1, RAC1, RHOA, CDC42) or microtubule-binding proteins (e.g. MAPT/TAU, MAP2, MAP1B), and modulates actin dynamics to regulate neurite growth and/or spine morphogenesis. Phosphorylates also exocytosis associated proteins such as MCAM/MUC18, SEPT5, SYN1, and CDK16/PCTAIRE1 as well as endocytosis associated proteins such as DNM1, AMPH and SYNJ1 at synaptic terminals. In the mature central nervous system (CNS), regulates neurotransmitter movements by phosphorylating substrates associated with neurotransmitter release and synapse plasticity; synaptic vesicle exocytosis, vesicles fusion with the presynaptic membrane, and endocytosis. Promotes cell survival by activating anti-apoptotic proteins BCL2 and STAT3, and negatively regulating of JNK3/MAPK10 activity. Phosphorylation of p53/TP53 in response to genotoxic and oxidative stresses enhances its stabilization by preventing ubiquitin ligase-mediated proteasomal degradation, and induces transactivation of p53/TP53 target genes, thus regulating apoptosis. Phosphorylation of p35/CDK5R1 enhances its stabilization by preventing calpain-mediated proteolysis producing p25/CDK5R1 and avoiding ubiquitin ligase-mediated proteasomal degradation. During aberrant cell-cycle activity and DNA damage, p25/CDK5 activity elicits cell-cycle activity and double-strand DNA breaks that precedes neuronal death by deregulating HDAC1. DNA damage triggered phosphorylation of huntingtin/HTT in nuclei of neurons protects neurons against polyglutamine expansion as well as DNA damage mediated toxicity. Phosphorylation of PXN reduces its interaction with PTK2/FAK1 in matrix-cell focal adhesions (MCFA) during oligodendrocytes (OLs) differentiation. Negative regulator of Wnt/beta-catenin signaling pathway. Activator of the GAIT (IFN-gamma-activated inhibitor of translation) pathway, which suppresses expression of a post-transcriptional regulon of proinflammatory genes in myeloid cells; phosphorylates the linker domain of glutamyl-prolyl tRNA synthetase (EPRS) in a IFN-gamma-dependent manner, the initial event in assembly of the GAIT complex. Phosphorylation of SH3GLB1 is required for autophagy induction in starved neurons. Phosphorylation of TONEBP/NFAT5 in response to osmotic stress mediates its rapid nuclear localization. MEF2 is inactivated by phosphorylation in nucleus in response to neurotoxin, thus leading to neuronal apoptosis. APEX1 AP-endodeoxyribonuclease is repressed by phosphorylation, resulting in accumulation of DNA damage and contributing to neuronal death. NOS3 phosphorylation down regulates NOS3-derived nitrite (NO) levels. SRC phosphorylation mediates its ubiquitin-dependent degradation and thus leads to cytoskeletal reorganization. May regulate endothelial cell migration and angiogenesis via the modulation of lamellipodia formation. Involved in dendritic spine morphogenesis by mediating the EFNA1-EPHA4 signaling. The complex p35/CDK5 participates in the regulation of the circadian clock by modulating the function of CLOCK protein: phosphorylates CLOCK at 'Thr-451' and 'Thr-461' and regulates the transcriptional activity of the CLOCK-ARNTL/BMAL1 heterodimer in association with altered stability and subcellular distribution..
Protein Sequence MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
3Ubiquitination-----MQKYEKLEKI
-----CCHHHHHHHC
54.82-
4Phosphorylation----MQKYEKLEKIG
----CCHHHHHHHCC
11.0428978645
6Acetylation--MQKYEKLEKIGEG
--CCHHHHHHHCCCC
59.8825953088
9AcetylationQKYEKLEKIGEGTYG
CHHHHHHHCCCCCCC
67.4623954790
9MalonylationQKYEKLEKIGEGTYG
CHHHHHHHCCCCCCC
67.4626320211
9UbiquitinationQKYEKLEKIGEGTYG
CHHHHHHHCCCCCCC
67.46-
9SumoylationQKYEKLEKIGEGTYG
CHHHHHHHCCCCCCC
67.46-
14PhosphorylationLEKIGEGTYGTVFKA
HHHCCCCCCCEEEEE
17.9321945579
15PhosphorylationEKIGEGTYGTVFKAK
HHCCCCCCCEEEEEC
22.9622322096
17PhosphorylationIGEGTYGTVFKAKNR
CCCCCCCEEEEECCC
16.6221945579
20UbiquitinationGTYGTVFKAKNRETH
CCCCEEEEECCCCCE
54.86-
20AcetylationGTYGTVFKAKNRETH
CCCCEEEEECCCCCE
54.8625953088
20MethylationGTYGTVFKAKNRETH
CCCCEEEEECCCCCE
54.86-
22MethylationYGTVFKAKNRETHEI
CCEEEEECCCCCEEE
58.07-
22UbiquitinationYGTVFKAKNRETHEI
CCEEEEECCCCCEEE
58.07-
33AcetylationTHEIVALKRVRLDDD
CEEEEEEEEEECCCC
38.8325953088
33UbiquitinationTHEIVALKRVRLDDD
CEEEEEEEEEECCCC
38.83-
46O-linked_GlycosylationDDDEGVPSSALREIC
CCCCCCCHHHHHHHH
26.3227316643
46PhosphorylationDDDEGVPSSALREIC
CCCCCCCHHHHHHHH
26.3220873877
47PhosphorylationDDEGVPSSALREICL
CCCCCCHHHHHHHHH
25.8320873877
56UbiquitinationLREICLLKELKHKNI
HHHHHHHHHHCCCCE
48.3119608861
56AcetylationLREICLLKELKHKNI
HHHHHHHHHHCCCCE
48.3119608861
56MalonylationLREICLLKELKHKNI
HHHHHHHHHHCCCCE
48.3126320211
72PhosphorylationRLHDVLHSDKKLTLV
EHHHHHCCCCCEEEE
47.1417192257
74UbiquitinationHDVLHSDKKLTLVFE
HHHHCCCCCEEEEEE
53.34-
74AcetylationHDVLHSDKKLTLVFE
HHHHCCCCCEEEEEE
53.3425953088
75UbiquitinationDVLHSDKKLTLVFEF
HHHCCCCCEEEEEEE
52.25-
88UbiquitinationEFCDQDLKKYFDSCN
EECCHHHHHHHHHCC
54.43-
89UbiquitinationFCDQDLKKYFDSCNG
ECCHHHHHHHHHCCC
59.45-
105PhosphorylationLDPEIVKSFLFQLLK
CCHHHHHHHHHHHHH
19.1121712546
128UbiquitinationNVLHRDLKPQNLLIN
CCCCCCCCHHCEEEC
49.1721890473
141UbiquitinationINRNGELKLADFGLA
ECCCCCEEEHHHHHH
37.012190698
158PhosphorylationFGIPVRCYSAEVVTL
HCCCEEEEEEEEEEE
10.6022817900
159PhosphorylationGIPVRCYSAEVVTLW
CCCEEEEEEEEEEEE
22.9119276087
167PhosphorylationAEVVTLWYRPPDVLF
EEEEEEEECCCCCCC
19.1618083107
213UbiquitinationNDVDDQLKRIFRLLG
CCHHHHHHHHHHHHC
37.50-
229PhosphorylationPTEEQWPSMTKLPDY
CCHHHCCCCCCCCCC
35.8027251275
231PhosphorylationEEQWPSMTKLPDYKP
HHHCCCCCCCCCCCC
33.4920071362
232UbiquitinationEQWPSMTKLPDYKPY
HHCCCCCCCCCCCCC
49.75-
236PhosphorylationSMTKLPDYKPYPMYP
CCCCCCCCCCCCCCC
16.3620071362
237SumoylationMTKLPDYKPYPMYPA
CCCCCCCCCCCCCCC
45.51-
237UbiquitinationMTKLPDYKPYPMYPA
CCCCCCCCCCCCCCC
45.51-
239PhosphorylationKLPDYKPYPMYPATT
CCCCCCCCCCCCCCC
9.1122817900
242PhosphorylationDYKPYPMYPATTSLV
CCCCCCCCCCCCHHH
5.8025884760
245O-linked_GlycosylationPYPMYPATTSLVNVV
CCCCCCCCCHHHHHH
16.6527316643
246O-linked_GlycosylationYPMYPATTSLVNVVP
CCCCCCCCHHHHHHH
23.3627316643
247PhosphorylationPMYPATTSLVNVVPK
CCCCCCCHHHHHHHC
26.4328857561
247O-linked_GlycosylationPMYPATTSLVNVVPK
CCCCCCCHHHHHHHC
26.4327316643
254UbiquitinationSLVNVVPKLNATGRD
HHHHHHHCCCCCCHH
42.64-
268UbiquitinationDLLQNLLKCNPVQRI
HHHHHHHCCCCCCCC
34.82-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
15YPhosphorylationKinaseABL1P00519
Uniprot
15YPhosphorylationKinaseEPHA4P54764
Uniprot
15YPhosphorylationKinaseFYNP06241
Uniprot
15YPhosphorylationKinaseABL-FAMILY-GPS
47SPhosphorylationKinaseCDK5Q00535
PSP
77TPhosphorylationKinasePRKCDQ05655
GPS
159SPhosphorylationKinaseCSNK1A1P48729
GPS
159SPhosphorylationKinaseCK1-FAMILY-GPS
159SPhosphorylationKinaseCK1_GROUP-PhosphoELM

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
14TPhosphorylation

15689152
159SPhosphorylation

10500146
159SPhosphorylation

10500146

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of CDK5_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
LMTK2_HUMANLMTK2physical
12832520
NEST_HUMANNESphysical
12832492
NDEL1_HUMANNDEL1physical
11163260
CD5R1_HUMANCDK5R1physical
11389014
CCND2_HUMANCCND2physical
9422379
PAK1_HUMANPAK1physical
11604394
CDK16_HUMANCDK16physical
12084709
CD5R1_HUMANCDK5R1physical
11583627
P53_HUMANTP53physical
17591690
CD5R1_HUMANCDK5R1physical
17591690
PRKN_HUMANPARK2physical
17327227
SDS3_MOUSESuds3physical
15489224
NEST_HUMANNESphysical
17036052
TLN1_HUMANTLN1physical
19363486
BAG6_HUMANBAG6physical
21900206
HEM1_HUMANALAS1physical
21900206
H10_HUMANH1F0physical
12970441
CD5R1_HUMANCDK5R1physical
22654103
FZR1_HUMANFZR1physical
22654103
RL34_HUMANRPL34physical
10049762
RB_HUMANRB1physical
10049762
DAB1_HUMANDAB1physical
18076569
DYN1_HUMANDNM1physical
15834155
KI26B_HUMANKIF26Bphysical
22768111
ODFP1_HUMANODF1physical
17762160
CD5R1_HUMANCDK5R1physical
17762160
AMPH_HUMANAMPHphysical
17419807
TAU_HUMANMAPTphysical
9735171
MBP_HUMANMBPphysical
17906618
HTRA2_HUMANHTRA2physical
17906618
A4_HUMANAPPphysical
21832049
GBP1_HUMANGBP1physical
22939629
TAU_HUMANMAPTphysical
12387894
CDN1B_HUMANCDKN1Bphysical
23543736
H15_HUMANHIST1H1Bphysical
11516829
PPARG_HUMANPPARGphysical
22078880
CDK5_HUMANCDK5physical
23602568
CDN1A_HUMANCDKN1Aphysical
23602568
CDN1B_HUMANCDKN1Bphysical
23602568
C2CD5_HUMANC2CD5physical
23602568
CCNB1_HUMANCCNB1physical
23602568
CABL1_HUMANCABLES1physical
23602568
FIBP_HUMANFIBPphysical
23602568
TMM94_HUMANKIAA0195physical
23602568
CABL2_HUMANCABLES2physical
23602568
CCND2_HUMANCCND2physical
23602568
DCLK3_HUMANDCLK3physical
23602568
CCND3_HUMANCCND3physical
23602568
CD5R1_HUMANCDK5R1physical
23602568
STIP1_HUMANSTIP1physical
23602568
CCNE1_HUMANCCNE1physical
23602568
FIBP_HUMANFIBPphysical
23455922
DHE3_HUMANGLUD1physical
23455922
HS90A_HUMANHSP90AA1physical
23455922
HS90B_HUMANHSP90AB1physical
23455922
CCNB1_HUMANCCNB1physical
23455922
TCPA_HUMANTCP1physical
23455922
CCNA2_HUMANCCNA2physical
23455922
CCND2_HUMANCCND2physical
23455922
CCND3_HUMANCCND3physical
23455922
CDN1A_HUMANCDKN1Aphysical
23455922
TCPZ_HUMANCCT6Aphysical
23455922
CDN1B_HUMANCDKN1Bphysical
23455922
TCPE_HUMANCCT5physical
23455922
TCPG_HUMANCCT3physical
23455922
TCPQ_HUMANCCT8physical
23455922
TCPD_HUMANCCT4physical
23455922
TCPB_HUMANCCT2physical
23455922
CDK3_HUMANCDK3physical
23455922
CDK18_HUMANCDK18physical
23455922
TMM94_HUMANKIAA0195physical
23455922
TRAP1_HUMANTRAP1physical
23455922
C2CD5_HUMANC2CD5physical
23455922
CABL1_HUMANCABLES1physical
23455922
TCPH_HUMANCCT7physical
23455922
CABL2_HUMANCABLES2physical
23455922
PPARG_HUMANPPARGphysical
22584573
TAU_HUMANMAPTphysical
9353289
TAU_HUMANMAPTphysical
19527721
CABL1_HUMANCABLES1physical
25852190
CABL2_HUMANCABLES2physical
25852190
CCNB1_HUMANCCNB1physical
25852190
CCNI_HUMANCCNIphysical
25852190
TCPB_HUMANCCT2physical
25852190
TCPG_HUMANCCT3physical
25852190
TCPD_HUMANCCT4physical
25852190
TCPE_HUMANCCT5physical
25852190
TCPZ_HUMANCCT6Aphysical
25852190
TCPH_HUMANCCT7physical
25852190
TCPQ_HUMANCCT8physical
25852190
CDK3_HUMANCDK3physical
25852190
CDN1B_HUMANCDKN1Bphysical
25852190
FIBP_HUMANFIBPphysical
25852190
TMM94_HUMANKIAA0195physical
25852190
C2CD5_HUMANC2CD5physical
25852190
TAU_HUMANMAPTphysical
17078951
C2CD5_HUMANC2CD5physical
26186194
CCNB1_HUMANCCNB1physical
26186194
CDN1B_HUMANCDKN1Bphysical
26186194
CABL1_HUMANCABLES1physical
26186194
CDK20_HUMANCDK20physical
26186194
CDK14_HUMANCDK14physical
26186194
RPE_HUMANRPEphysical
26344197
CHIP_HUMANSTUB1physical
26206088
FZR1_HUMANFZR1physical
18818692
MPIP1_HUMANCDC25Aphysical
22899714
MPIP2_HUMANCDC25Bphysical
22899714
MPIP3_HUMANCDC25Cphysical
22899714
YBOX3_HUMANYBX3physical
10100871
C2CD5_HUMANC2CD5physical
28514442
CABL1_HUMANCABLES1physical
28514442
CCNB1_HUMANCCNB1physical
28514442
CDK20_HUMANCDK20physical
28514442
CDN1B_HUMANCDKN1Bphysical
28514442
CDK3_HUMANCDK3physical
28514442
CDK14_HUMANCDK14physical
28514442
CCNE1_HUMANCCNE1physical
28514442
SHLB1_HUMANSH3GLB1physical
27173435
PRCC_HUMANPRCCphysical
27173435
SEPT7_HUMANSEPT7physical
27173435
CHRD1_HUMANCHORDC1physical
27173435
SARNP_HUMANSARNPphysical
27173435
COPZ1_HUMANCOPZ1physical
27173435
GORS2_HUMANGORASP2physical
27173435
SEP11_HUMANSEPT11physical
27173435
DRG1_HUMANDRG1physical
27173435
FYV1_HUMANPIKFYVEphysical
28637746
CD5R1_HUMANCDK5R1physical
28637746

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
616342Lissencephaly 7, with cerebellar hypoplasia (LIS7)
Kegg Drug
D09604 Dinaciclib (USAN/INN)
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of CDK5_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-56, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-14; TYR-15; THR-17;SER-46; SER-72 AND TYR-239, AND MASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-15; THR-17 AND SER-72,AND MASS SPECTROMETRY.
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-15, AND MASSSPECTROMETRY.
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells.";
Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.;
J. Proteome Res. 8:3852-3861(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-15, AND MASSSPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-15, AND MASSSPECTROMETRY.
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer.";
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
Cell 131:1190-1203(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-15, AND MASSSPECTROMETRY.

TOP